Should I take low dose aspirin? The 'Optimise' decision aid study

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1067062

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

An aspirin per day reduces cancer risk as well as protecting against heart disease and stroke. It's readily available, affordable and could potentially reduce the two most common causes of death and disease in Australia. However, aspirin also increases the chance of bleeding and that needs to be weighed up against the potential benefits. The challenge for patients and their healthcare providers is personalising this evidence for the individual patient. Our study develops and tests an online tool that does just that.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $437,337.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Primary Health Care

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

aspirin | cancer prevention | cardiovascular disease prevention | decision making | primary care | translational research

Related Links